Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

BACKGROUND: While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostate cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Mouillet, Guillaume, Efficace, Fabio, Thiery‐Vuillemin, Antoine, Charton, Emilie, Van Hemelrijck, Mieke, Sparano, Francesco, Anota, Amélie
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7571808/
https://ncbi.nlm.nih.gov/pubmed/32846465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados